The Promus Element Rewards Study
NCT01794065 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2014-08-11
Summary
This study is being done to study stent deformation on persons with de novo coronary lesions to determine how much deformation takes place and how often. The information gathered from the group that receives the Promus element stent will be compared to other groups that receive other contemporary drug eluting stents.
Conditions
- Coronary Stenosis
Sponsors & Collaborators
-
Medstar Health Research Institute
lead OTHER
Principal Investigators
-
Ron Waksman, MD · Medstar Health Research Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
NCT01342822 ·Status: UNKNOWN
-
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
NCT01331707 ·Status: COMPLETED ·Phase: PHASE4
-
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NCT01703000 ·Status: COMPLETED ·Phase: NA
-
Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis
NCT00493597 ·Status: COMPLETED
-
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT01995487 ·Status: COMPLETED ·Phase: NA
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent
NCT02280720 ·Status: COMPLETED ·Phase: PHASE4
-
Post-Approval Study of PROMUS Element™ in China
NCT01677585 ·Status: COMPLETED
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
NCT03189641 ·Status: COMPLETED ·Phase: NA
-
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
NCT01835301 ·Status: UNKNOWN
-
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00369356 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PLATINUM Diversity
NCT02240810 ·Status: COMPLETED
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents
NCT01073111 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)
NCT02060357 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents
NCT00598715 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
NCT00824434 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions
NCT00693979 ·Status: UNKNOWN ·Phase: PHASE1
-
Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease
NCT03301246 ·Status: COMPLETED ·Phase: NA
-
Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
NCT02176265 ·Status: COMPLETED ·Phase: NA
-
First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
NCT02236975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3